Correvio Pharma Corp. Depreciation and Amortization
Correvio Pharma Corp. reported Depreciation and Amortization of $3.76 million for the 12-month period ending 2019-12-31, per its 20-F filed 2020-04-30.
Discontinued › Cash Flow › Operating Activities
us-gaap:DepreciationDepletionAndAmortization · last filed 2020-04-30
| Period end | Depreciation, Depletion and Amortization 12 month |
|---|---|
| 2019-12-31 | $3.76M 20-F · filed 2020-04-30 |
| 2018-12-31 | $4.02M 20-F · filed 2020-04-30 |
| 2017-12-31 | $3.37M 20-F · filed 2020-04-30 |